Atea Pharmaceuticals, Inc. (AVIR) vs Opus Genetics, Inc. (IRD)
Atea Pharmaceuticals, Inc. and Opus Genetics, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Opus Genetics, Inc. are of similar size ($414.7M and $405.2M). Atea Pharmaceuticals, Inc. has the higher net margin (0.00% vs −1,091.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Atea Pharmaceuticals, Inc. leads on 7 and Opus Genetics, Inc. on 7.
Valuation
Profitability
| Metric | AVIR | IRD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (513.47%) | 0.00% |
| Net margin | 0.00% | (1,091.82%) | 0.00% |
| Free cash flow margin | 0.00% | (412.61%) | 0.00% |
| Return on equity | (58.14%) | (4,796.52%) | (57.72%) |
| Return on assets | (52.99%) | (163.50%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack